Together, these findings highlight PABPC1L, SNHG17 and SNHG1 as the most promising candidate biomarkers for distinguishing colorectal tumors from adjacent non-tumor tissues, with PABPC1L showing the most favorable balance of sensitivity and specificity. This evidence concerns the gene SNHG17 and colorectal neoplasm.